VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Kyiv, Ukraine, 25-28 May 2004
Overall Goal:
Contribute towards a sustainable progress of public health in the CEE and NIS region by sharing experiences and knowledge that will help to reinforce the current vaccination programmes and facilitate the introduction of future vaccines.
Objectives of the meeting:
Tuesday, May 25th 2004
SESSION 1: OPENING SESSION
18.00-19.00 Welcome by:
Nedret Emiroglu, WHO
Olga Lapushenko, Ministry of Health, Ukraine
Dragoslav Popovic, UNICEF
Mark Kane, Children’s Vaccine Program
Review of the objectives of the meeting and technical introduction
Wednesday, May 26th 2004
08.30-09.00 REGISTRATION (continued)
SESSION 2: GENERAL INTRODUCTION
09.00 - 09.20 Global Epidemiology and prevention of hepatitis B
Steven Wiersma, WHO
09.20 - 09.40 Overview of GAVI and the Vaccine Fund
Tore Godal, GAVI
09.40 - 10.00 GAVI in the WHO European Region: results, current situation, and future
Andrei Lobanov, WHO
SESSION 3: EPIDEMIOLOGY AND PREVENTION OF VIRAL HEPATITIS AND HEAMOPHILUS INFLUENZAE TYPE B
10.30 - 10.50 Epidemiology of hepatitis B and vaccination programmes in the WHO European Region
Nedret Emiroglu, WHO
10.50 - 11.00 Discussion
11.00 - 11.20 Hepatitis C epidemiology in CEE and NIS countries
Hal Margolis, CDC
11.20 - 11.30 Discussion
11.30 - 11.50 HBV, HCV, and HIV integrated programmes
Michael Favorov, CDC
11.50 - 12.00 Discussion
14.00 - 14.20 Burden of disease of Haemophilus influenzae type b in the WHO European Region
Andrei Lobanov, WHO
14.20 - 14.30 Discussion
SESSION 4: COUNTRY EXPERIENCES: HEPATITIS B PREVENTION STRATEGIES AND PROGRAMME EVALUATION[15 minutes presentation and 5 minutes discussion time for each topic]
14.30 - 14.50 Introduction of a newborn hepatitis B immunisation programme in Turkey
Ebru Usta and Selim Badur, Turkey
14.50 - 15.10 Achievements with newborn and catch up hepatitis B immunisation programme in Kazakhstan
Tatiana Surdina, Kazakhstan
15.10 - 15.30 Assessment of implementation of the hepatitis B prevention programme in Georgia
Lia Dzhabidze, Georgia
16.00 - 16.20 Evaluation of hepatitis B prevention strategies in the Russian Federation
Marina Shevyreva, Russian Federation
16.20 - 16.40 Experience with sentinel surveillance in Kyrgyzstan
Rafik Usmanov, Kyrgyzstan
16.40 - 17.00 Acute Viral Hepatitis Surveillance for Hepatitis B Vaccine Evaluation Program
Liudmila Mosina, CDC
Thursday, May 27th 2004
SESSION 5: SAFETY ISSUES
09.00 - 09.20 Safety and quality of hepatitis B vaccines: Frequently asked questions in the WHO European Region
Philippe Duclos, WHO
09.20 - 09.40 The importance of communication on immunisation safety
Dragoslav Popovic, UNICEF
09.40 - 10.00 Injection safety of immunisation in the WHO European Region
Denis Maire, WHO
10.00 - 10.15 Blood safety in Central Asia Region
Aliya Jumagulova, CDC
10.15 - 10.30 Safe sharps waste collection and management in Samarkand, Uzbekistan
Erkin Musabaev, Uzbekistan
10.30 - 11.00 Discussions
SESSION 6: STRENGTHENING IMMUNISATION SYSTEMS: PROCUREMENT AND FINANCING
11.30 - 11.50 Vaccine supply in CEE and NIS
Katinka Aanjesen, UNICEF
11.50 - 12.10 Potential role of group procurement in the WHO European Region
Alan Brooks, CVP/PATH
12.10 - 12.30 Discussions
14.00 - 14.20 Financial sustainability planning
Viktor Galyada, CVP/PATH
14.20 - 14.35 Financial sustainability planning of Uzbekistan
Dilorom Tursunova, Uzbekistan
14.35 - 14.50 e-learning resource to strengthen financial planning of immunization
Molly Mort and Alan Brooks, CVP/PATH
14.50 - 15.10 Discussions
SESSION 7A: TECHNICAL WORKSHOP: HOW TO MONITOR AND EVALUATE HEPATITIS B IMMUNISATION PROGRAMMES AND TO SET SURVEILLANCE TARGETS
Chairs: Susan Goldstein, CDC; Johannes Hallauer, VHPB
15.30 - 15.55 Overview of methods to evaluate the impact hepatitis B immunization programs
Susan Goldstein, CDC
15.55 - 16.20 Practical aspects of conducting acute disease surveillance
Rafik Usmanov, Kyrgyzstan
16.20 - 16.45 Laboratory aspects of acute disease surveillance and the need for QA/QC
Tatiana Kalashnikova, CDC
16.45 - 17.10 Protocol to conduct serologic surveys
Luidmila Mosina, CDC
17.10 - 17.35 WHO protocol for serologic surveillance
Steven Wiersma, WHO
17.35 - 18.00 Open Discussion
SESSION 7B: TECHNICAL WORKSHOP: HEPATITIS B VACCINES
Chairs: Wolfgang Jilg, VHPB; Paolo Bonanni,VHPB; Pierre Van Damme, VHPB
15.30 - 15.40 Introduction
15.40 - 16.00 Birth dose: what is possible in view of other vaccines, combined vaccines, etc
Reflections on schedules, dosage, vaccines and inter-changeability of hepatitis B vaccines
Mark Kane,CVP/PATH or Pierre Van Damme, VHPB
16.00 - 16.30 Duration of protection after hepatitis B vaccination: current status
Wolfgang Jilg, VHPB
16.30 - 16.45 Current experience in Italy
Paolo Bonanni, VHPB
16.45 - 17.00 Review of current recommendations regarding booster vaccination
Daniel Lavanchy, WHO
17.00 - 17.30 Country experience on current vaccination policy: booster, schedules, vaccine, doses, etc.:
Workshop discussion with country participants
17.30 - 17.50 Pre- and post-vaccination testing and the issue of non-responders
Fransisco Averhoff, CDC
17.50 - 18.00 Final open questions and answers to facilitators/ conclusions
SESSION 7C: TECHNICAL WORKSHOP: HOW TO MANAGE A VACCINE SAFETY CRISIS IN YOUR COUNTRY: WHAT TO DO, WHAT TO AVOID? (ADVOCACY, SOCIAL MOBILIZATION)
Chairs: Dragoslav Popovic, UNICEF; Philippe Duclos, WHO
15.30 - 15.45 Introduction of participants, objectives of the workshop, agenda
15.45 - 15.55 Why and how to deal with media?
15.55 - 16.35 Press Conference: Role play
16.35 - 17.20 Case studies: Response to safety crisis and development of a checklist on “crisis management”
Group Work
17.20 - 17.40 Rapport from the working groups/discussion
17.40 - 18.00 How to access major sources in communication for immunization
Discussion
SESSION 7D: GAVI WORKSHOP: FINANCIAL SUSTAINABILITY PLANS (FSP)
Chairs: Andrei Lobanov,WHO; Viktor Galyada,CVP/PATH; Alan Brooks, CVP/PATH
15.30 - 15.45 Introduction
15.45 - 16.25 Countries briefly describe the development process
16.25 - 16.40 Implementation of FSP in Kyrgyzstan
Ludmila Shteinke, Kyrgyztan
16.40 - 17.15 Countries describe what is being done to maintain rolling financial planning for immunization, including implement strategies in the FSP
17.15 - 17.45 Getting the 2004 process started
17.45 - 18.00 Final open questions and answers to facilitators or other countries
Friday, May 28th 2004
SESSION 8: FEEDBACK OF THE WORKSHOPS
09.00 - 09.15 Feedback on workshop 7A: How to monitoring and evaluate hepatitis B immunisation programmes and set surveillance targets
09.15 - 09.25 Discussion
09.25 - 09.40 Feedback on workshop 7B: Technical aspects of hepatitis B vaccines
09.40 - 09.50 Discussion
09.50 - 10.05 Feedback on workshop 7C: How to manage a vaccine safety crisis in your country
10.05 - 10.15 Discussion
10.15 - 10.30 Feedback on workshop 7D: Financial sustainability plans
10.30 - 10.40 Discussion
SESSION 9: CONCLUSIONS OF THE MEETING AND CLOSING REMARKS
11.10 - 12.00 Conclusions and summary of the meeting
Alexandra Levitt
BREAK-OUT SESSION FOR COUNTRIES RECEIVING SUPPORT FROM GAVI / VACCINE FUND
14.00 - 17.00 A programme of the session will be provided